Skip to main content
SpringerLink
Log in

Contrast-Induced Nephropathy

  • Chapter
Pediatric Nephrology in the ICU

  • 1353 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Asif A, Epstein M (2004) Prevention of radiocontrast induced nephropathy. Am J of Kidney Dis 44:12–24

    Article  CAS  Google Scholar 

  2. Bakris GI, Lass N, Gaber AO, et al. (1990) Contrast media induced decline in renal function: a role for oxygen free radicals. Am J Physiol 258:115–120

    Google Scholar 

  3. Barrett BJ, Carlisle EJ (1993) Meta analysis of the relative nephrotoxicity of high and low osmolarity iodinated contrast media. Radiology 188:171–178

    PubMed  CAS  Google Scholar 

  4. Berg KJ (2000) Nephrotoxicity related to contrast media. Scan J Urol Nephrol 34:317–322

    Article  CAS  Google Scholar 

  5. Berns J, Ridnick M (1992) Contrast associated nephrotoxicity. Kidney 24:1–5

    Google Scholar 

  6. Brezis M, Rosen AS (1995) Hypoxia of the renal medulla: its implications for disease. N Engl J Med 332:647–655

    Article  PubMed  CAS  Google Scholar 

  7. Broome DR, Girguis MS, Baron PW, et al. (2007) Gadolinium associated nephrogenic systemic fibrosis: why radiologists should be concerned. AJR 188:586–592

    Article  PubMed  Google Scholar 

  8. Chamsuddin AA, Kowalik KJ, Bjarnason H, et al. (2002) Using a dopamine type 1A receptor agonist in high risk patients to ameliorate contrast associated nephropathy. AJR Am J Roentgenol 179:591–596

    PubMed  Google Scholar 

  9. Cigarroa RG, Lange RA, Williams RH, et al. (2001) Dosing of contrast material to prevent CIN. Am J Med 111:692–698

    Article  Google Scholar 

  10. Cochran ST, Wong WS, Roe DJ (1983) Predicting angiography induced acute renal function impairment: clinical risk model. AJR 141:1027–1033

    PubMed  CAS  Google Scholar 

  11. Cox CD, Tsikouris JP (2004) Preventing contrast nephropathy: what is the best strategy? J Clin Pharmacol 44:327–337

    Article  PubMed  Google Scholar 

  12. Eisenberg RL, Bank WO, Hedgock MW (1981) Renal failure after major angiography can be avoided with hydration. AJR 136:859–861

    PubMed  CAS  Google Scholar 

  13. el Sayed AA, Haylor JL, el Nahas AM (1991) Haemodynamic effects of water-soluble contrast media on the isolated perfused rat kidney. Br J Radiol 64:435–439

    Article  PubMed  CAS  Google Scholar 

  14. Fang L, Sirota R, Ebert T, et al. (1981) Low fractional excretion of sodium with CIN acute renal failure. Arch Intern Med 141:1652–1656

    Article  Google Scholar 

  15. Finn WF (2006) The clinical and renal consequences of contrast induced nephropathy. Nephrol Dial Transplant 21:2–10

    Article  Google Scholar 

  16. Fishbane S (2008) N-Acetylcysteine in the prevention of contrast-induced nephropathy. Clin J Am Soc Nephrol 3:281–287

    Article  PubMed  CAS  Google Scholar 

  17. Gleeson TG, Bulugahapitiya S (2004) CIN. AJR 183:1673– 1689

    PubMed  Google Scholar 

  18. Grobner T (2006) Gadolinium—a specific trigger for the development of nephrogenic systemic fibrosis? Nephrol Dial Transplant 21:1104–1108

    Article  PubMed  CAS  Google Scholar 

  19. Gupta RK, Kapoor A, Tewari S, et al. (1999) Captopril for prevention of CIN in diabetic patients. Indian Heart J 51:521–526

    PubMed  CAS  Google Scholar 

  20. Hirsch R, Dent C, Pfriem H, et al. (2007) NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol 22:2089–2095

    Article  PubMed  Google Scholar 

  21. Huber W, Ilgmann K, Page M (2002) Effect of theophylline on CIN in patients with chronic renal insufficiency. Radiology 223:772–779

    Article  PubMed  CAS  Google Scholar 

  22. Katholi R (2006) CIN: update and practical clinical applications. US Cardiovasc Dis 2:73–80

    Google Scholar 

  23. Katholi RE, Taylor GJ, McCann W P, et al. (1995) Nephrotoxicity from contrast media: attenuation with theophylline. Radiology 195:17–22

    PubMed  CAS  Google Scholar 

  24. Katzberg RW (1997) Urography in the 21st century. Radiology 204:297–312

    PubMed  CAS  Google Scholar 

  25. Khurana A, Runge VM, Narayanan M, et al. (2007) Nephrogenic systemic fibrosis: a review of 6 cases related to gadolinium injection. Invest Radiol 42:139–145

    Article  PubMed  Google Scholar 

  26. Koch JA, Plus J, Grabensee B, et al. (2000) Prostaglandin E1: a new agent for the prevention of renal dysfunction in high risk patients caused by contrast media? Nephrol Dial Transplant 15:43–49

    Article  PubMed  CAS  Google Scholar 

  27. Kolonko A, Wiecek A (1998) CIN: old clinical problem with new therapeutic options. Nephrol Dial Transplant 13:803–806

    Article  PubMed  CAS  Google Scholar 

  28. Kriss VM, Cottrill C, Gurley JC (1997) CO2 angiography in children. Pediatric Radiol 27:807–810

    Article  CAS  Google Scholar 

  29. Lehnert T, Keller E, Condolf K, et al. (1998) Effect of hemodialysis after contrast administration in patients with renal insufficiency. Nephrol Dial Transplant 13:358–362

    Article  PubMed  CAS  Google Scholar 

  30. Lin J, Bonventre JV (2005) Prevention of radiocontrast nephropathy. Curr Opin Nephrol Hypertens 14:105–110

    PubMed  CAS  Google Scholar 

  31. Maddox TG (2002) Adverse reactions to contrast material: recognition, prevention and treatment. Am Fam Physician 66:1229–1234

    PubMed  Google Scholar 

  32. Madyoon H, Croushore L, Weaver D, et al. (2001) Use of fenoldopam to prevent CIN in high risk patients. Cathet Cardiovasc Interv 53:341–345

    Article  CAS  Google Scholar 

  33. Manske CL, Sprafka JM, Strony JT, et al. (1990) Contrast nephropathy in azotemic diabetic patients. Am J Med 89:615–620

    Article  PubMed  CAS  Google Scholar 

  34. Marckmann P, Skov L, Rossen H, et al. (2006) Nephrogenic systemic fibrosis: suspected etiological role of gadolinium used for contrast enhanced MRI. J Am Soc Nephrol 17:2359–2362

    Article  PubMed  Google Scholar 

  35. Marenzi G, Marana I, Lauri G, et al. (2003) The prevention of CIN by hemofiltration. N Engl J Med 349:1333–1340

    Article  PubMed  CAS  Google Scholar 

  36. Margulies K, Schirger J, Burnett J Jr (1992) Radiocontrast induced nephropathy: current status and future prospects. Int Angiol 11:20–25

    PubMed  CAS  Google Scholar 

  37. McCullough PA, Wolyn R, Rocher LL, et al. (1997) Acute renal failure after coronary intervention incidence, risk factors and relationship to mortality. Am J Med 103:368–374

    Article  PubMed  CAS  Google Scholar 

  38. McCullough PA, Sandberg KR (2003) Epidemiology of CIN. Rev Cardiovasc Med 4:3–9

    Google Scholar 

  39. McCullough PA, Soman SS (2005) Contrast-induced nephropathy. Crit Care Clin 21:261–280

    Article  PubMed  Google Scholar 

  40. Merten GJ, Burgess W P, Gray LV, et al. (2004) Prevention of CIN with sodium bicarbonate: a randomized trial. JAMA 291:2328–2334

    Article  PubMed  CAS  Google Scholar 

  41. Morcos SK (1998) CIN: questions and answers. Br J Radiol 71:357–365

    PubMed  CAS  Google Scholar 

  42. Murphy S W, Barrett BJ, Parfrey PS (2000) Contrast nephropathy. J Am Soc Nephrol 11:177–182

    PubMed  CAS  Google Scholar 

  43. Parfrey PS, Griffiths SM, Barrett BJ (1989) Contrast material induced renal failure in patients with diabetes, renal insufficiency or both. N Engl J Med 320:143–153

    PubMed  CAS  Google Scholar 

  44. Prasad P V, Proatna A, Spokes K, et al. (2000) Changes in intrarenal oxygenation as evaluated by BOLD MRI in a rat kidney model for CIN. J Magn Reson Imaging 13:744–747

    Article  Google Scholar 

  45. Rudnick M, Berns J, Cohen R, et al. (1994) Nephrotoxic risks of angiography: a critical review. Am J Kidney Dis 24:713–727

    PubMed  CAS  Google Scholar 

  46. Shammas NW, Kapalis MJ, Harris M, et al. (2002) Aminophylline does not protect against CIN in patients undergoing angiographic procedure. J Invasive Cardiol 13:738–740

    Google Scholar 

  47. Shyu KG, Cheng JJ, Kuan P (2002) Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing coronary procedure. J Am Coll Cardiol 40:1383–1388

    Article  PubMed  CAS  Google Scholar 

  48. Solomon R (1998) Contrast medium induced acute renal failure. Kidney Int 53:230–242

    Article  PubMed  CAS  Google Scholar 

  49. Solomon R, Werner C, Mann D, et al. (1994) Effects of saline, mannitol and furosemide on acute diseases in renal function induced by radiocontrast agents. N Engl J Med 331:1416–1420

    Article  PubMed  CAS  Google Scholar 

  50. Stevens MA, McCullough PA, Tobin KJ, et al. (1999) A randomized trial of prevention measures in patients at high risk for CIN. J Am Coll Cardiol 33:403–411

    Article  PubMed  CAS  Google Scholar 

  51. Taliercio C P, Vlietstra RE, Ilstrup DM, et al. (1991) A randomized comparison of the nephrotoxicity of iopamidol and diatrizoate in high risk patients. J Am Coll Cardiol 17:384–390

    Article  PubMed  CAS  Google Scholar 

  52. Telep M, van der Giet M, Schwarzfeld C, et al. (2000) Prevention of CIN by acetylcysteine. N Engl J Med 343:180–184

    Article  Google Scholar 

  53. Tommaso C (1994) Contrast induced nephrotoxicity in patients undergoing cardiac catheterization. Cathet Cardiovasc Diagn 31:316–321

    Article  PubMed  CAS  Google Scholar 

  54. Trivedi HS, Moore H, Nasr S, et al. (2003) A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 93:29–34

    Article  Google Scholar 

  55. Tublin ME, Murphy ME, Tessler FN (1998) Current concepts in CIN. AJR 171:933–939

    PubMed  CAS  Google Scholar 

  56. Tumlin JA, Wang A, Murray PT, et al. (2002) Fenoldopam blocks reduction in renal blood flow after contrast infusion. Am Heart J 143:894–903

    Article  PubMed  CAS  Google Scholar 

  57. Vlietstra RE, Nunn CM, Narvarte J, et al. (1996) Contrast nephropathy after coronary angioplasty in chronic renal insufficiency. Am Heart J 132:1049–1050

    Article  PubMed  CAS  Google Scholar 

  58. Vogt B, Ferrari P, Schonholzer C, et al. (2001) Prophylactic hemodialysis after contrast administration in patients with renal insufficiency is potentially harmful. Am J Med 111:692–698

    Article  PubMed  CAS  Google Scholar 

  59. Waybill MM, Waybill PN (2001) CIN: identification of patients at risk and algorithms for prevention. J Vasc Interv Radiol 12:3–9

    Article  PubMed  CAS  Google Scholar 

  60. Weisberg LS, Kurnik PB, Kurnik BR (1992) CIN in humans: role of renal vasoconstriction. Kidney Int 41:1408–1415

    Article  PubMed  CAS  Google Scholar 

  61. Wong GT, Irwin MG (2007) Contrast-induced nephropathy. Br J Anaesth 99:474–483

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology and Pediatrics, University of Kentucky and Kentucky Children's Hospital, Lexington, KY, 40536, USA

    V. M. Kriss

Authors
  1. V. M. Kriss
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. G. Kiessling
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Pediatric Nephrology and Renal Transplantation, Kentucky Children's Hospital University of Kentucky, 740 South Limestone Street Room J460, Lexington, KY, 40536, USA

    Stefan G. Kiessling

  2. Nephrology and Hypertension Division Medical Director, Kidney Transplantation Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229-3039, USA

    Jens Goebel

  3. Division of Nephrology, Harvard Medical School Children's Hospital Boston, 300 Longwood Avenue, Boston, MA, 02115, USA

    Michael J. G. Somers

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kriss, V.M., Kiessling, S.G. (2009). Contrast-Induced Nephropathy. In: Kiessling, S.G., Goebel, J., Somers, M.J.G. (eds) Pediatric Nephrology in the ICU. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-74425-2_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-74425-2_20

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-74423-8

  • Online ISBN: 978-3-540-74425-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation